114 related articles for article (PubMed ID: 3012610)
1. Hyperendorphinemia in obesity and relationships to affective state.
Facchinetti F; Giovannini C; Barletta C; Petraglia F; Buzzetti R; Burla F; Lazzari R; Genazzani AR; Scavo D
Physiol Behav; 1986; 36(5):937-40. PubMed ID: 3012610
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of plasma pro-opiomelanocortin-related peptides in neurotic depression.
Genazzani AR; Petraglia F; Sinforiani E; Brambilla F; Facchinetti F; Nappi G
Acta Endocrinol (Copenh); 1986 May; 112(1):1-6. PubMed ID: 2940793
[TBL] [Abstract][Full Text] [Related]
3. Plasma B-endorphin resistance to dexamethasone suppression in obese patients.
Facchinetti F; Giovannini C; Petraglia F; Barletta C; Comitini G; Genazzani AR
J Endocrinol Invest; 1988 Feb; 11(2):119-23. PubMed ID: 2834430
[TBL] [Abstract][Full Text] [Related]
4. Hyperendorphinemia in obesity is not related to the affective state.
Scavo D; Barletta C; Vagiri D; Burla F; Fontana M; Lazzari R
Physiol Behav; 1990 Nov; 48(5):681-3. PubMed ID: 1964503
[TBL] [Abstract][Full Text] [Related]
5. Plasma endogenous opioids and dexamethasone suppression test in depression.
Kärkkäinen J; Laatikainen T; Naukkarinen H; Salminen K; Spoov J; Stenman UH; Rimon R
Psychiatry Res; 1987 Jun; 21(2):151-9. PubMed ID: 2956623
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous circadian variations of plasma ACTH, beta-lipotropin, beta-endorphin and cortisol.
Petraglia F; Facchinetti F; Parrini D; Micieli G; De Luca S; Genazzani AR
Horm Res; 1983; 17(3):147-52. PubMed ID: 6303934
[TBL] [Abstract][Full Text] [Related]
7. Hyperendorphinemia in obese children and adolescents.
Genazzani AR; Facchinetti F; Petraglia F; Pintor C; Corda R
J Clin Endocrinol Metab; 1986 Jan; 62(1):36-40. PubMed ID: 2933422
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone fails to suppress hyperendorphinaemia of obese children.
Facchinetti F; Livieri C; Petraglia F; Cortona L; Severi F; Genazzani AR
Acta Endocrinol (Copenh); 1987 Sep; 116(1):90-4. PubMed ID: 2958981
[TBL] [Abstract][Full Text] [Related]
9. Impairment of adrenergic-induced proopiomelanocortin-related peptide release in heroin addicts.
Facchinetti F; Volpe A; Nappi G; Petraglia F; Genazzani AR
Acta Endocrinol (Copenh); 1985 Jan; 108(1):1-5. PubMed ID: 2857510
[TBL] [Abstract][Full Text] [Related]
10. Proopiocortin-related peptide plasma levels throughout prepuberty and puberty.
Genazzani AR; Facchinetti F; Pintor C; Puggioni R; Parrini D; Petraglia F; Bagnoli F; Corda R
J Clin Endocrinol Metab; 1983 Jul; 57(1):56-61. PubMed ID: 6304136
[TBL] [Abstract][Full Text] [Related]
11. Plasma immunoreactive beta-endorphin in dexamethasone suppressors and non-suppressors of cortisol.
Norman TR; Piperoglou M; McIntyre IM; Lynch C; Burrows GD
J Affect Disord; 1987; 12(3):233-9. PubMed ID: 3038984
[TBL] [Abstract][Full Text] [Related]
12. The elevation of plasma beta-endorphin levels in major depression.
Goodwin GM; Austin MP; Curran SM; Ross M; Murray C; Prentice N; Ebmeier KP; Bennie J; Carroll S; Dick H
J Affect Disord; 1993 Dec; 29(4):281-9. PubMed ID: 8126314
[TBL] [Abstract][Full Text] [Related]
13. beta-Endorphin and adrenocortical function in obesity.
Zelissen PM; Koppeschaar HP; Erkelens DW; Thijssen JH
Clin Endocrinol (Oxf); 1991 Oct; 35(4):369-72. PubMed ID: 1752064
[TBL] [Abstract][Full Text] [Related]
14. Multiple HPA profiles in endogenous depression: effect of age and sex on cortisol and beta-endorphin.
Akil H; Haskett RF; Young EA; Grunhaus L; Kotun J; Weinberg V; Greden J; Watson SJ
Biol Psychiatry; 1993 Jan; 33(2):73-85. PubMed ID: 8382535
[TBL] [Abstract][Full Text] [Related]
15. Primary headaches: reduced circulating beta-lipotropin and beta-endorphin levels with impaired reactivity to acupuncture.
Facchinetti F; Nappi G; Savoldi F; Genazzani AR
Cephalalgia; 1981 Dec; 1(4):195-201. PubMed ID: 6290071
[TBL] [Abstract][Full Text] [Related]
16. The response of plasma immunoreactive adrenocorticotropin, beta-endorphin/beta-lipotropin, gamma-lipotropin and cortisol to experimentally induced pain in normal subjects.
Güllner HG; Nicholson WE; Wilson MG; Bartter FC; Orth DN
Clin Sci (Lond); 1982 Oct; 63(4):397-400. PubMed ID: 6286207
[TBL] [Abstract][Full Text] [Related]
17. Endogenous opioids and hypothalamic-pituitary-adrenal function in obesity and anorexia nervosa.
Cavagnini F; Invitti C; Dubini A; Danesi L; Silvestri G; Passamonti M; Magella A; Morabito F
Adv Biochem Psychopharmacol; 1987; 43():273-81. PubMed ID: 3035891
[No Abstract] [Full Text] [Related]
18. Dissociation between CSF and plasma B-endorphin in major depressive disorders: evidence for a different regulation.
Facchinetti F; Petraglia F; Sances G; Garuti C; Tosca P; Nappi G; Genazzani AR
J Endocrinol Invest; 1986 Feb; 9(1):11-4. PubMed ID: 3009596
[TBL] [Abstract][Full Text] [Related]
19. Impaired circadian rhythmicity of beta-lipotrophin, beta-endorphin and ACTH in heroin addicts.
Facchinetti F; Grasso A; Petraglia F; Parrini D; Volpe A; Genazzani AR
Acta Endocrinol (Copenh); 1984 Feb; 105(2):149-55. PubMed ID: 6320568
[TBL] [Abstract][Full Text] [Related]
20. beta-Endorphin/beta-lipotropin immunoreactivity in endogenous depression. Effect of dexamethasone.
Matthews J; Akil H; Greden J; Charney D; Weinberg V; Rosenbaum A; Watson SJ
Arch Gen Psychiatry; 1986 Apr; 43(4):374-81. PubMed ID: 2937385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
